Clinical Trial Update: Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating intensive lipid-lowering therapy in non-ST-elevation acute coronary syndrome patients; current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Acute Coronary Syndrome

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Acute Coronary Syndrome | Phase 4 | Status: UNKNOWN